OVERVIEW
Irritable bowel syndrome (IBS) is one of the most common gastrointestinal complaints seen in primary care and a major cause of referral to gastroenterology. In this live Spotlight, a panel of 3 clinician experts will use patient cases to discuss and review the diagnosis and management of both constipation-predominant (IBS-C) and diarrhea-predominant (IBS-D) IBS from the primary care perspective, including diet and lifestyle management, as well as over-the-counter and prescription medications. Audience polling questions and a live Q&A will create an engaging and interactive learning activity.
GOAL STATEMENT
The goal of this activity is for learners to be better able to diagnose and manage IBS in their practices using the latest clinical evidence and professional guidelines.
LEARNING OBJECTIVES
Upon completion of this activity, participants will: Have increased knowledge regarding the[list][item]Use of culturally competent communication to engage with patients who present with gastrointestinal symptoms suggestive of IBS[/list]Have greater competence related to[list][item]Diagnosing IBS based on current clinical evidence-based recommendations[item]Creating individualized treatment plans that account for patient goals and preferences[/list]
ACCREDITATION STATEMENT
[MEDSCAPE][JALOGO] In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
[bold]For Physicians[/bold] Medscape, LLC designates this live activity for a maximum of 0.5 [italic][bold]AMA PRA Category 1 Credit[/bold][/italic]™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Supported by an independent educational grant from [bold]Mahana Therapeutics, Inc[/bold]. and [bold]Salix Pharmaceuticals, Inc[/bold].